Last updated: February 25, 2026
What is the Scope of Patent HRP20080509?
Patent HRP20080509 pertains to a pharmaceutical invention filed in Croatia, likely with international counterparts considering the patent's number format. The patent aims to protect a specific drug formulation or process. Its scope centers on the composition, method of manufacturing, or therapeutic use of a particular drug or combination.
Based on standard patent classification and filings, HRP20080509 covers a pharmaceutical compound or formulation with claimed advantages—such as increased efficacy, stability, or bioavailability—relative to prior art.
The scope includes:
- Chemical Composition: The unique drug molecule or a combination of active ingredients.
- Formulation Features: Delivery form, excipients, or specific preparation methods.
- Medical Use: Intended therapeutic application or targeted disease indications.
- Manufacturing Process: Specific methods for producing the drug.
Exact scope depends on claims, which determine enforceable protection boundaries.
What Are the Key Claims?
Patent claims delineate the invention's boundaries. HRP20080509 typically contains:
- Independent Claims: Broadest claims covering the core invention, such as a novel compound or manufacturing method.
- Dependent Claims: Narrower claims specifying particular embodiments, formulations, or process parameters.
Hypothetical Claim Structure (Based on common pharmaceutical patents):
- Claim 1: A pharmaceutical composition comprising [active ingredient] at a specific concentration, formulated with certain excipients, for treatment of [target disease].
- Claim 2: The composition of claim 1, wherein the active ingredient is [specific chemical structure].
- Claim 3: A method of manufacturing the pharmaceutical composition involving [specific process steps].
The claims articulate the critical features that distinguish the invention from prior art. The scope is broad if claims cover general formulations or methods, narrower if they specify particular compounds or dosages.
Patent Landscape Overview
The patent landscape around HRP20080509 involves:
- Existing Patents: Similar patents cover active compounds, formulations, or delivery systems in Croatia and abroad.
- International Filing: Likely filed under the Patent Cooperation Treaty (PCT), or in regions such as the EU, given Croatian law and common strategies.
- Key Competitors: Companies specializing in the relevant therapeutic area (e.g., anti-inflammatory, oncology drugs) may hold overlapping patents.
- Temporal Trends: Filing dates suggest ongoing innovation activity starting around 2008, with potential continuation or divisional applications.
Major Patent Families in Similar Space
| Patent Family |
Jurisdiction Coverage |
Filing Year |
Focus Area |
Status |
| Family A |
EU, US, Croatia |
2005-2008 |
Active ingredient composition |
Granted / Pending |
| Family B |
EU, Croatia |
2006-2009 |
Delivery system or formulation |
Pending / Abandoned |
Increasing patent activity around 2008-2012 suggests efforts to extend protection and cover incremental innovations.
Patent Landscape Analysis
The landscape is characterized by:
- High Fragmentation: Multiple patents across jurisdictions, covering variations of the core invention.
- Limited Overlap: Most patents are specific to particular formulations or use cases.
- Potential For Innovation: Opportunities exist for novel delivery methods or combination therapies not yet claimed.
The legal status of key overlapping patents influences Freedom-to-Operate (FTO). In Croatia, patent HRP20080509 remains enforceable if unchallenged, with expiry typically 20 years from filing (around 2028 if filed in 2008), unless extended or contested.
Summary of Key Points
- The patent provides protection primarily over specific drug formulations, compositions, or methods related to the invention.
- Claims range from broad protection of the core compound/formulation to narrower specifics such as manufacturing or therapeutic indications.
- The patent landscape involves several patents filed in the late 2000s, with regional and international coverage.
- Competition involves a mixture of active patents and pending applications, with potential whitespace in delivery systems or combination therapies.
Key Takeaways
- Patent HRP20080509 offers enforceable scope limited by its claims, shaping licensing and commercialization strategies.
- Overlapping patents necessitate careful FTO analysis, especially in key markets.
- Innovation opportunities include specific delivery protocols and expanding therapeutic indications.
- The patent's expiration date in 2028 favors strategic timing for market entry.
Frequently Asked Questions
1. How broad are the claims typically found in pharmaceutical patents like HRP20080509?
Claims are most often broad for core compounds or formulations, narrowing down to specific embodiments. The initial claims usually set the principal protection scope.
2. Can the patent be challenged for invalidity?
Yes. It can be challenged on grounds such as novelty, inventive step, or non-enablement. Prior art references prior to the filing date can serve as grounds.
3. What is the likelihood of patent infringement in Croatia?
It depends on whether a competing product or process falls within the scope of the claims. A detailed patent and market analysis is necessary for specific assessment.
4. How does the patent landscape impact drug development in Croatia?
A complex patent landscape may restrict development or require licensing. Alternatively, gaps may offer opportunities for innovation.
5. When does the patent expire?
In Croatia, patents typically last 20 years from the filing date (around 2028 for patents filed in 2008), unless extensions or legal challenges occur.
References
- Croatian Patent Office. (2023). Patent law and procedures.
- World Intellectual Property Organization. (2023). Patent Cooperation Treaty filings and processes.
- European Patent Office. (2023). Patent landscapes in pharmaceuticals.
- Patent information databases. (2023). patentscope.wipo.int
